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A B S T R A C T
Depression has been implicated as a possible risk factor for low bone mineral density (BMD). However, there is still no
solid evidence that could connect these two different illnesses. This research examined the association between self-re-
ported depression and low BMD in perimenopausal and postmenopausal women. This research screened 130 female pa-
tients who were 44 to 72 years old and registered at the densitometry clinic of KBC Rijeka during a three month period.
Densitometry was performed in order to establish their BMD and according to the results two groups of participants were
formed: normal BMD – 38 participants with normal BMD at hip and spine and reduced BMD – 75 participants with
lower BMD at hip and spine. Depression was assessed using Beck depression inventory. Both groups of participants were
compared regarding their depression scores. There were no significant differences between the groups with normal and
reduced BMD regarding mean age, age of menopause, length of menopause and number of births (p=0.001). Difference
regarding depressiveness between the two groups was not significant (t=0.73; p=0.468). Also, there were no differences
between the groups regarding the frequency of certain levels of depression. (c2=2.27; p=0.52). Results of this research
suggest that self-reported depression is not associated with low BMD in perimenopausal and postmenopausal women.
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Introduction
Osteoporosis is a disease characterized by low bone
mineral density (BMD). In addition, many patients ex-
hibit ostopenia, reduced bone mineral density (BMD)
level that is indicative of being at high risk for osteoporo-
sis. BMD has been shown to be a risk for fracture1 and
patients are usually not aware of having thinning bones
until they experience vertebral, hip, or other types of
fracture. Recent years have seen increase of incidence of
osteoporosis, which can be attributed to the overall aging
of general population. Osteoporosis can be divided into
primary and secondary, based on its etiology and patho-
genesis. Primary osteoporosis includes involution osteo-
porosis (postmenopausal osteoporosis and osteoporosis
of older age), along with idiopathic osteoporosis. Meno-
pause and older age are the most significant factors con-
tributing to the development of primary osteoporosis.
Most severe loss of bone mass in postmenopausal osteo-
porosis happens in spongy bones, but in senile osteo-
porosis in cortical bones. Secondary osteoporosis occurs
secondary to other diseases and disorders. Most frequent
causes of secondary osteoporosis are endocrine disorders
(hypogonadism, hyperthyreosis, hyperparathyreosis, dia-
betes mellitus, and Cushing syndrome), hematologic ill-
nesses, effects of certain medications (corticosteroids)2,3,
chronic illnesses (rheumatic illnesses, some gastrointes-
tinal disorders, malignancies), chronic alcohol abuse,
stress and according to some researches, depression4.
Depression has been implicated as a possible risk fac-
tor for low BMD5. However, researches regarding depres-
sion and BMD are inconsistent as some studies showed a
relationship between depression and BMD and others
did not6,7.
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Research among perimenopausal women in Australia
showed a connection between higher self-report of de-
pression and lower hip BMD8.
According to some researches, depression shows al-
tered regulation of hypothalamus-pituitary-adrenal gland
cortex axis, along with inhibited growth hormone release
and decreased functioning of thyroid gland, gonads and
immunologic system. Perimenopausal women that suffer
from depression show greater bone mass loss, that could
be a consequence of altered pituitary – adrenal gland cor-
tex axis and its effects on bone turnover. In older age,
cortisol secretion is increased during evening and night
time, although secretion of cortisol during the day is nor-
mal. It has been shown that this disturbance in the daily
cycle of cortisol secretion can alter bone mass density9,10.
Other researches confirm existence of several direct
pathways through which depression or dysthymia could
lower proximal femoral BMD. For example, persistently
elevated plasma cortisol levels have been associated with
clinical depression11 and also with low BMD12.
Based on clinical experience of endocrinologists it has
been noted that people suffering from osteoporosis are
more often depressive, compared to other patients. The-
refore, psychiatrists and endocrinologists from Clinical
Hospital Centre in Rijeka performed screening of pa-
tients referred to densitometric scans in order to objecti-
fy depressive symptoms. The aim of this research was to
compare patients with normal and lowered bone mass in
regard to their depressive symptoms.
Patients and Methods
Patients
This research screened 130 patients that registered at
the densitometry clinic of KBC Rijeka during a three
month period. Further selection of patients was perfor-
med on the basis of gender and age and research included
44 to 72 year old female patients. Exclusion criteria
were: established clinical depression, cognitive impair-
ments, severe physical illnesses, decreased eyesight and
any other physical and psychical state that could influ-
ence patient’s capability to participate in this research or
lower the reliability of obtained data.
17 patients out of 130 that were screened were ex-
cluded from the research. 11 due to age requirements (ei-
ther older than 72 or younger than 44) and 6 due to fail-
ure to complete given questionnaires. There were no
patients excluded according to exclusion criteria.
Patients that satisfied inclusion criteria and accepted
to participate in this research were informed about the
research. They also signed informed consent about par-
ticipating in the research and completed given question-
naires, as well as performed densitometric scans. The
whole procedure took roughly 40 minutes to complete.
Methods
Instruments used in this research were: general ques-
tionnaire, Beck depression inventory (BDI)13 and densi-
tometric scans.
General questionnaire
This questionnaire was used in order to acquire gen-
eral demographic data such as: age, height, weight, length
of menopause, number of childbirths and smoking habit.
Beck depression inventory (BDI)
Depressive symptoms were assessed according to the
Beck depression inventory (BDI)13. This inventory is a
21-item self-report instrument intended to assess the ex-
istence and severity of symptoms of depression. Individ-
ual questions of the BDI asses mood, pessimism, sense of
failure, self-dissatisfaction, guilt, punishment, self-dis-
like, self-accusation, suicidal ideas, crying, irritability, so-
cial withdrawal, body image, work difficulties, insomnia,
fatigue, appetite, weight loss, bodily preoccupation, and
loss of libido.
Every question of the BDI can be answered according
to the severity of problems, from 0 to 3. Results were in-
terpreted as follows: 0–11 – no clinical depression, 12–19
– mild depression, 20–26 – moderate depression and over
26 – severe depression.
Densitometry
This method was used to asses BMD (posteroanterior
scans of vertebrae and left hip) with a DXA method on a
Hologic Delphy machine. Accuracy of the method used
for the area of lumbal spine is 1%, maximal up to 3%, and
for the hip area 1–3%, maximal up to 5%14–16. Osteoporo-
sis is defined by the World Health Organization (WHO)
in women as a bone mineral density 2.5 standard devia-
tions below peak bone mass (20-year-old healthy female
average) as measured by DXA. Severe osteoporosis is
when T-value is 2,5 standard deviations below peak bone
mass and one or more pathological fractures are present.
Osteopenia is a condition with bone mineral density be-
tween 1 and 2,5 standard deviations below peak bone
mass17,18.
Based on densitometry results, participants were di-
vided into two groups: normal BMD – 38 participants
that do not have lower spine and hip BMD and reduced
BMD – 75 participants with lower spine or/and hip BMD.
Those two groups were compared in regard to their de-
pression scores and symptoms.
Statistical analysis
Basic descriptive statistical parameters were analy-
zed – arithmetic means and standard deviation for con-
tinuing variables, frequency and percentage of certain
cases for categorical variables. Differences between
groups regarding continuing variables were calculated
using a t-test for independent samples and for variables
expressed in frequencies chi-square test. Pearson’s corre-
lation coefficient was used to research possible connec-
tions between variables.
Results
Normal BMD group consisting of 38 participants was
compared to the reduced BMD group consisting of 75 pa-
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tients. There were no significant differences between the
two groups regarding mean age, age of menopause, length
of menopause, number of births, number of smokers (Ta-
ble 1). Normal BMD group was significantly taller (t=
3.24; p= 0.002), heavier (t= 5.05; p<0.001) and had a
higher BMI (t= 03.99; p< 0.001).
Results of this research showed that 14 participants
from the normal BMD group and 28 from the reduced
BMD group were depressed. Two groups did not signifi-
cantly differ regarding depressive symptoms (Table 2)
(t= 0.73; p= 0.468).
There were no differences between the two groups in
regard to frequency of certain levels of depression (Table
3) (c2= 2.27; p= 0.52).
In the normal BMD group age, height, weight, BMI,
age of menopause, length of menopause, number of births,
number of smokers did not significantly correlate with
depression (p>0.05). In the reduced BMD groups age,
height, BMI, age of menopause, length of menopause,
number of births, number of smokers did not signifi-
cantly correlate with depression (p>0.05). While weight
was negatively correlated with depression (r = –0.24; p=
0.037).
Discussion
Our research showed no statistically significant dif-
ferences between groups with normal and reduced BMD
in regard to depression (Table 2).
Connection between depression and osteoporosis is
still an insufficiently researched area of medicine and re-
sults thus far are inconsistent. Petronijevi} and associ-
ates found that premenopausal women with depression
have significantly lower BMD due to stimulated bone cell
metabolism with predomination of osteoresorption pro-
cesses, mostly due to decreased physical activity of pa-
tients suffering from depression19. Michelson and associ-
ates measured bone mineral density at the hip, spine,
and radius and compared 24 women with past or current
depression with 24 normal women, and suggested that
past or current depression in women is associated with
decreased bone mineral density11.
Contrary to these reports Yazici and Ozsoy concluded
that major depression is not associated with any alter-
ation in BMD20,21.
Some studies showed that mostly premenopausal wo-
men suffering from depression are at greater risk of de-
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TABLE 1
GENERAL SAMPLE CHARACTERISTICS
Group Normal BMD N=38 t, ÷2/p Reduced BMD N=75
Age
mean
standard deviation
57.87
7.200
t=1.087
0.279
59.21
5.653
Age of menopause
mean
standard deviation
49.03
5.451
t=0.090
0.929
48.93
5.100
Length of menopause
mean
standard deviation
10.40
6.524
t=0.048
0.962
10.47
6.608
Height
mean
standard deviation
166.789
6.609
t=3.237
0.002
163.2
4.897
Weight
mean
standard deviation
77.816
11.282
t=5.050
<0.001
66.82
10.74
BMI
mean
standard deviation
28.00
4.064
t=3.987
<0.001
25.04
3.549
Number of births
0 – 4 (10.5%)
1 – 11 (28.9%)
³2 – 23 (60.5%)
÷2=0.534
0.766
0 – 13 (12.0%)
1 – 37 (34.7%)
³2 – 63 (63.5%)v
Non-smoker 31 (81.6%)
÷2=0.077
0.781
58 (77.3%)
Smoker 7 (18.4%) 17 (22.7%)
TABLE 2
NUMBER AND PERCENTAGE OF PARTICIPANTS WITH NORMAL
AND REDUCED BMD REGARDING DEPRESSIVE SYMPTOMS
Group
Without
depression
Depression
÷2 / P
N (%) N (%)
Normal BMD 24 (63.8) 14 (36.8)
0.00 / 1.00
Reduced BMD 47 (62.7) 28 (37.3)
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veloping osteoporosis, while that risk was not greater in
perimenopausal and postmenopausal women. Our re-
search confirmed these findings. Altindag and associates
stated that depression should be considered as a risk fac-
tor for osteoporosis in premenopausal women22. Span-
gler in the study of postmenopausal women observed
minimal association between depressive symptoms and
3-year changes in BMD or fracture risk23.
Whole series of articles and researches were per-
formed in order to clarify possible connection of depres-
sion and reduced bone mineral density. However, there is
still no solid evidence that could connect these two differ-
ent illnesses. One of the possible reasons is that all these
researches were very different in their design. Several re-
searches were performed on a larger number of partici-
pants and in postmenopausal women. Robbins and asso-
ciates conducted a research on a random sample of 1,566
Medicare enrollees, women and men, age 65 and older
and found a significant association between BMD and de-
pressive symptoms24. Laudisio and associates, in a popu-
lation based study of 306 men with a mean age of 75, sug-
gested that assessment for depression should be perfor-
med in older men with diagnosis of osteoporosis25. Other
authors performed their research on smaller samples of
participants and in younger population. Kavuncu and as-
sociates matched 42 healthy women with 42 patients di-
agnosed with depression and concluded that low BMD
was not a prominent feature of premenopausal woman
with mild depression, even though an increase in bone
resorption was found26. Eskandari and associates repor-
ted baseline BMD measurements in 89 premenopausal
women with MDD and 44 healthy controls and concluded
that low BMD is more prevalent in premenopausal wo-
men with MDD27.
Participants in this research assessed their depress-
iveness through a self-report questionnaire for depres-
sion, but have never been diagnosed or treated for depres-
sion. Majority of research conducted until now compared
clinically depressed patients suffering from major de-
pressive disorder and healthy volunteers28,29.
We used Beck Depression Inventory in order to evalu-
ate the severity of depression and did not find any corre-
lation between depression and BMD. On the other hand,
Coelho and associates performed a research among 40–
80 year old women and established that women with os-
teoporosis have significantly higher levels of depressive
symptoms30.
Some of the reasons which could clarify results of this
research are its limitations: relatively small sample of
participants, women included were in perimenopause as
well as postmenopause (we can speculate that results
would be different if this research included only women
in perimenopause or postmenopause), grade of BMD was
not measured and due to that fact it was not possible to
perform certain correlation analysis. As no clinically de-
pressed patients were enrolled in this research we ex-
pected, and results confirmed these expectations, that
participants would be less frequently depressive or that
their depression would be of lower intensity (Table 3).
Out of all the variables that were correlated to de-
pressiveness, only weight in reduced BMD group was
negatively correlated to depression.
In conclusion, women in perimenopause or postme-
nopause that do not suffer from clinical depression and
have never been treated for depression do not share a
connection between their depressiveness and reduced
BMD.
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POVEZANOST DEPRESIJE I GUBITKA MINERALNE GUSTO]E KOSTIJU U @ENA
U PERIMENOPAUZI I POSTMENOPAUZI
S A @ E T A K
Depresija se smatra mogu}im rizi~nim ~imbenikom za nisku mineralnu gusto}u kostiju (BMD). No, jo{ uvijek nema
~vrstih dokaza koji bi povezivali ove dvije razli~ite bolesti. Ovim istra`ivanjem se ispitivala povezanost izme|u samo-
prijavljene depresije i niskog BMD u perimenopauzalnih i postmenopauzalnih `ena. Ovo istra`ivanje je obuhvatilo 130
`ena u dobi od 44 do 72 godine koje su se javile u denzitometrijski centar KBC-a Rijeka tijekom tromjese~nog perioda
promatranja. U~injena je denzitometrija kako bi se ustanovila mineralna gusto}a kostiju te su po dobivenim rezulta-
tima formirane dvije skupine ispitanica: one s normalnom mineralnom gusto}om kostiju – 38 ispitanica s normalnim
BMD kuka i kralje`nice i one sa sni`enommineralnom gusto}om kostiju – 75 ispitanica sa sni`enim BMD kuka i kralje-
`nice. Depresija je procjenjivana Beckovim samoprocjenskim upitnikom. Obje skupine su uspore|ivane po rezultatima
na navedenom upitniku. Nije bilo zna~ajnih razlika izme|u skupina s normalnim i sni`enim BMD glede srednje dobi,
dobi menopauze, trajanju menopauze i broja poroda (p=0,001). Razlika u depresivnosti izme|u dvije skupine nije bila
zna~ajna (t=0,73; p=0,468). Nadalje, nisu ustanovljene razlike izme|u skupina glede u~estalosti odre|enih razina de-
presije (c2-test 2,27; p=0,52). Rezultati ovog istra`ivanja sugeriraju da samoprijavljena depresija nije povezana sa sni-
`enom mineralnom gusto}om kostiju u perimenopauzalnih i postmenopauzalnih `ena.
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